Bank of America
WX

Bank of America’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bank of America’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-567,730
Closed -$24.5M – 7684
2015
Q3 		$24.5M Buy
567,730
+423,596
+294% +$17.9M 0.01% 1458
2015
Q2 		$6.09M Sell
144,134
-81,858
-36% -$3.45M ﹤0.01% 2395
2015
Q1 		$8.76M Sell
225,992
-680,729
-75% -$26.2M ﹤0.01% 1985
2014
Q4 		$30.5M Sell
906,721
-229,623
-20% -$8.11M 0.01% 1110
2014
Q3 		$39.8M Buy
1,136,344
+33,969
+3% +$1.16M 0.01% 961
2014
Q2 		$36.2M Sell
1,102,375
-157,401
-12% -$5.39M 0.01% 1001
2014
Q1 		$46.4M Sell
1,259,776
-144,064
-10% -$5.29M 0.02% 798
2013
Q4 		$53.9M Buy
1,403,840
+79,922
+6% +$2.52M 0.02% 741
2013
Q3 		$36.3M Buy
1,323,918
+229,324
+21% +$5.43M 0.01% 875
2013
Q2 		$23M Buy
+1,094,594
New +$21.4M 0.01% 1101

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Bank of America's WX Position: Q4 2015 in Review

Bank of America sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 567,730 shares — an estimated $24.5M sold.

Bank of America first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $53.9M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Bank of America reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Bank of America sold 567,730 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $24.5M.
  • Bank of America first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Bank of America's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $53.9M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.